Peter Heerma
EVP, Chief Commercial Officer at Travere Therapeutics · 21 reported transactions in 1 company · latest trade Sep 17, 2026
Their trades
Sold | Sep 17, 2026 | Sep 17, 2026 close $64.74 → Oct 29, 2026 close $50.57. S&P 500 +0.9% over the same days. | ||
Sold | Sep 16, 2026 | Sep 16, 2026 close $63.48 → Oct 29, 2026 close $50.57. S&P 500 +2.0% over the same days. | ||
Sold | Sep 16, 2026 | Sep 16, 2026 close $63.48 → Oct 29, 2026 close $50.57. S&P 500 +2.0% over the same days. | ||
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days. | ||
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days. | ||
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days. |
$538.9K
Sep 17, 2026 close $64.74 → Oct 29, 2026 close $50.57. S&P 500 +0.9% over the same days.
$5.04M
Sep 16, 2026 close $63.48 → Oct 29, 2026 close $50.57. S&P 500 +2.0% over the same days.
$5.92M
Sep 16, 2026 close $63.48 → Oct 29, 2026 close $50.57. S&P 500 +2.0% over the same days.
$93.5K
Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days.
$89.1K
Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days.
$1.72M
Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days.